Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,063 public trials 1,834 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Recruiting

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT04429087

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

NCT07431827

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Instituto Alexander Fleming ( Site 0310) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Sanatorio Parque ( Site 0311) Rosario, Santa Fe Province, Argentina
  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0306) CABA, Argentina
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0309) CABA, Argentina
View all 72 locations
View Trial Details
Recruiting

An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

NCT05363319

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Klinikum Klagenfurt Klagenfurt, Carinthia, Austria
  • Salzburger Landeskliniken (SALK) Salzburg, Austria
  • Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital Mulhouse, Alsace, France
  • Hopitaux Universitaires de Strasbourg Strasbourg, Bas-Rhin, France
View all 49 locations
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

DBC-664 in Adult Patients With Solid Tumors

NCT07705035

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
  • START New York Lake Success, New York, United States
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

A Registry for People With Lung Cancer

NCT06424327

Conditions
Lung Cancer, Lung Cancer Stage I, Lung Diseases, +6 more
Locations
  • University of Arizona (Data Collection Only) Tucson, Arizona, United States
  • University of California San Diego (Data collection) San Diego, California, United States
  • Rush University Medical Center (Data collection only) Chicago, Illinois, United States
  • Endeavor Health Evanston, Illinois, United States
View all 18 locations
View Trial Details
Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

NCT06472245

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Research Advisors, LLC Beverly Hills, California, United States
  • Clinical Research Advisors - Encino Encino, California, United States
  • Clinical Research Advisors - West Hollywood Los Angeles, California, United States
  • Clinical Research Advisors - Korea Town Los Angeles, California, United States
View all 207 locations
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details

Related conditions